Adult ECAT protocol

Traumatic injury

A12.3 Published: July 2024. Printed on 21 Nov 2024.

QR code link to ECI website

Get the latest version


Any person, 16 years and over, presenting with blunt, penetrating, or other traumatic mechanism resulting in an actual or potential life or limb-threatening injury. Excludes burns.

This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.

Refer to local trauma criteria and:

  • escalate immediately as per local CERS protocol
  • consider trauma response, transfer and retrieval
  • activate critical blood loss, massive transfusion protocol or code crimson early, if required.

History prompts, signs and symptoms

These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.

History prompts

  • Presenting complaint
  • Mechanism of injury
  • Time of injury
  • Preceding events
  • Pain assessment – PQRST
  • Pre-hospital treatment (MIST)
  • Past admissions
  • Medical and surgical history
  • Current medications, including anticoagulant therapy
  • Non-prescription drug or alcohol use
  • Known allergies

Signs and symptoms

Refer to locally agreed trauma criteria.

  • Tachycardia
  • Hypotension
  • Haemorrhage
  • Open wounds
  • Pain
  • Bruising
  • Localised swelling
  • Sensory loss
  • Limb injury

Red flags

Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.

Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.

Historical

Mechanism of injury (MOI) PLUS high-risk group = high indicator for major trauma

High-risk group

  • Low-impact mechanisms, e.g. ground level falls and low-speed MVAs, may result in severe injury in patients over 65 years
  • Obstetric patients over 20 weeks gestation
  • Patients on anticoagulants, antiplatelet medications or with clotting disorders
  • Difficult to assess, e.g. language, communication differences or cognitive ability

Mechanism of injury

  • Death in the same vehicle
  • Intrusion into occupant compartment more than 30 cm
  • Steering wheel deformity
  • Patient side impact
  • Fall or collision in cyclist or motorcyclist
  • Vehicle vs pedestrian
  • Ejection from a vehicle
  • Entrapment with compression
  • Agricultural machinery or equipment
  • Quadbike or buggy
  • Livestock, e.g. horses or cattle
  • Crush injury, excluding fingers and toes
  • Falls over 3 m
  • Falls off ladder over 1 m
  • High voltage injury
  • Any rapid deceleration incident
  • Focal blunt trauma to head, chest or abdomen, e.g. implements, assault or bike handlebars
  • Hanging
  • All penetrating injuries

Clinical

  • Altered level of consciousness
  • Major blood loss
  • SBP less than 100 mmHg
  • Haemodynamic instability
  • Persistent tachycardia
  • Respiratory compromise
  • Facial injury with potential airway risk
  • Head injury with loss of consciousness or amnesia and one of:
    • seizure
    • 2 or more vomits
    • open, depressed skull fracture
    • signs of base of skull fracture
  • Neck injury with swelling, stridor or hoarseness
  • Suspicion of multiple rib fractures
  • Bruising to chest or abdomen, e.g. seatbelt sign
  • Pelvic pain or deformity
  • Proximal long bone fractures
  • Degloving injuries or amputation
  • Spinal or back pain with visible deformity, priapism or severe pain

Remember adult at risk: patient or carer concern, frailty, multiple comorbidities or unplanned return.

Clinical assessment and specified intervention (A to G)

If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.

Position

AssessmentIntervention

Suspected C-spine injury

All major trauma patients should be treated as having a spinal injury until proven otherwise

Stabilise the C-spine with in-line immobilisation and/or foam collar (appendix)

Airway

AssessmentIntervention

Patency of airway

Maintain airway patency

Consider airway opening manoeuvres and positioning

Do not perform head tilt and do not insert a nasopharyngeal airway, if there is any possibility of a fractured base of skull or nasal bone fracture

Breathing

AssessmentIntervention

Respiratory rate and effort

Auscultate chest (breath sounds)

Oxygen saturation (SpO2)

Assist ventilation, as clinically indicated

If patient meets major trauma criteria, apply oxygen

Consider oxygen if dyspnoeic, titrate oxygen to maintain SpO2 over 93%

Patients at risk of hypercapnia, maintain SpO2 at 88–92%

Tension pneumothorax

  • Asymmetrical chest movement
  • Unilateral or decreased breath sounds

Perform chest decompression, if trained

Open pneumothorax

  • Open, sucking chest wound
Cover with non-porous dressing taped on 3 sides only. Remove immediately if respiratory status deteriorates

Flail chest

  • Paradoxical chest wall movement
  • Respiratory distress
  • Hypoxia
  • Severe pain

Exclude pneumothorax

Circulation

AssessmentIntervention
Signs of external bleeding

Control external bleeding using direct pressure and/or elevation

In cases of limb haemorrhage, i.e. arterial bleeding, use a tourniquet, or keep in situ if applied pre-hospital, until advised by the trauma team

Perfusion (capillary refill, skin warmth and colour)

Pulse rate

Blood pressure

Cardiac rhythm

Assess circulation

Attach cardiac monitor and complete 12 lead ECG

IVC and/or pathology

If patient meets major trauma criteria, insert 2 large bore (18 gauge) IV cannulas, if trained

Insert IV cannula, if trained and clinically indicated

If unable to obtain IV access, consider intraosseous, if trained

If ongoing haemodynamic instability, escalate as per local CERS protocol for advice regarding blood products and activation of Critical Blood Loss or Massive Transfusion Protocol or Code Crimson

and give tranexamic acid, 1 g IV, once only

See pathology section

Signs of shock:

tachycardia and CRT 3 seconds and over

and/or abnormal skin perfusion

and/or hypotension

If signs of shock present and/or SBP less than 90 mmHg, give 250 mL of Hartmann’s or sodium chloride 0.9% IV/intraosseous bolus

Warmed fluids are preferred

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg or signs of shock have resolved

Pelvic injury

Consider pelvic binder if signs of shock, severe pain or high risk mechanism.

High risk mechanism may include:

  • crush injury
  • high speed, rollover or lateral impact MVA
  • ejection from a vehicle, partial or complete
  • vehicle vs pedestrian
  • death in the same vehicle

See pelvic binder appendix

Long bone injury

Apply a splint to any long bone injuries

Disability

AssessmentIntervention

GCS, pupillary response and limb strength

Obtain baseline and repeat assessment, as clinically indicated

If reduced GCS or unable to recall events, commence A-WPTAS. See specific treatment section

Pain
Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment

Exposure

AssessmentIntervention
Temperature

Aim for normothermia

If hypothermic, initiate slow re-warming with blankets, forced air device, warm IV fluids or blood

Measure core temperature if actively warming

Skin inspection, including posterior surfaces

Check and document any abnormalities

Fluids

AssessmentIntervention
Hydration status: last ate, drank, bowels opened, passed urine or vomited Commence fluid balance chart, including estimated blood loss
NBM NBM until medical review
Nausea and/or vomiting If present, see nausea and/or vomiting section
Gastrointestinal

Consider insertion of IDC if required and not contraindicated

Glucose

Assessment Intervention
BGL

Measure BGL

If BGL less than 4 mmol/L with NO decrease in level of consciousness (Yellow Zone criteria):

  • give 40% glucose gel, up to 15 g, buccal
  • reassess BGL in 15–30 minutes and repeat treatment until BGL over 4 mmol/L

If BGL less than 4 mmol/L WITH a decrease in level of consciousness (Red Zone criteria) OR the patient is unable to tolerate oral intake:

  • give 40% glucose gel, up to 15 g, buccally in incremental doses, as tolerated, while establishing IV access
  • give 10% glucose 200 mL by IV infusion over 15 minutes, once only
  • if delay in IV access, give glucagon 1 mg IM, once only
  • reassess BGL in 15 minutes

If the patient is unconscious or peri-arrest:

  • give 50% glucose 50 mL by slow IV injection, once only. Use with caution as extravasation can cause necrosis
  • if delay in IV access, give glucagon 1 mg IM, once only
  • reassess BGL in 15 minutes

Once stabilised, give patient long-acting carbohydrate and continue to check BGL hourly, or as clinically indicated

Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.

Focused assessment

Complete a secondary survey focused assessment.

Precautions and notes

  • Be aware of distracting painful injuries that may mask other and more serious injuries.
  • Tachycardia may not occur in athletes, elderly patients, those taking beta blocker agents or those suspected of spinal cord injury.
  • Be aware of severe injury in elderly patients with a low mechanism of injury.
  • Early use of blood products, if available, remains the optimal resuscitation fluid for the hypovolaemic patient. Escalate as per local CERS protocol.
  • Where blood is not available, or delayed, IV Hartmann’s solution is the preferred alternative for the initial resuscitation of the hypovolaemic trauma patient. IV sodium chloride 0.9% may be used as an alternative, however, large volumes may result in metabolic acidosis. Small volumes of fluid resuscitation are preferred, i.e. permissive hypotension, rather than aggressive fluid resuscitation.
  • Tranexamic acid is recommended in shocked trauma patients within 3 hours from the time of injury.

Interventions and diagnostics

Specific treatment

Limb threatening injury

  • Neutral alignment
  • Apply splint
  • Elevate the limb
  • Perform neurovascular limb observations.

Open fractures

  • Irrigate with sodium chloride 0.9% and apply a compress soaked in sodium chloride 0.9%.
  • Do not reposition protruding bone ends.
  • Stabilise limb.
  • Escalate care urgently as per local CERS protocol.

Amputation or partial amputation

  • If the digit, tissue or limb has been completely amputated:
    • Wrap the amputation in gauze soaked with sodium chloride 0.9%.
    • Place in a clean bag, and then in another bag with ice slurry.
    • Do not sit the amputation directly in the ice slurry.
  • If partial amputation:
    • Perform neurovascular exam.
    • Irrigate with sodium chloride 0.9% and apply dressing soaked in sodium chloride 0.9%.
  • Escalate care urgently as per local CERS protocol.

Suspected mid-shaft femur fracture

Impaled objects

  • Stabilise object. Do not remove.

Open abdominal injuries

  • Cover exposed viscera with moist saline packs.

Head injury

  • Repeat A-WPTAS if the score is less than 18/18.

Analgesia

Select pain score:

Pain score 1–3 (mild)

Give paracetamol 1000 mg orally once only

and/or ibuprofen 400 mg orally once only

Pain score 4–6 (moderate)

Give:

oxycodone (immediate release):

  • 16–65 years: 5 mg orally and, if required, repeat once after 30 minutes, maximum dose 10 mg
  • 65 years and over: 2.5 mg orally and, if required, repeat once after 30 minutes, maximum dose 5 mg

and/or paracetamol 1000 mg orally once only

and/or ibuprofen 400 mg orally once only

Pain score 7–10 (severe)

Give one of:

Fentanyl intranasal
  • 16–65 years: 50 microg intranasally and, if required, repeat once after 5 minutes, maximum dose 100 microg. Dose to be divided between nostrils
  • 65 years and over: 25 microg intranasally and, if required, repeat once after 5 minutes, maximum dose 50 microg. Dose to be divided between nostrils

Note: ensure an extra 0.1 mL is drawn up for the first dose to account for the dead space in the mucosal atomiser device

Fentanyl IV
  • 16–65 years: 50 microg IV and, if required, repeat once after 5 minutes, maximum dose 100 microg
  • 65 years and over: 25 microg IV and, if required, repeat once after 5 minutes, maximum dose 50 microg
Morphine IV
  • 16–65 years: 5 mg IV and, if required, repeat once after 5 minutes, maximum dose 10 mg
  • 65 years and over: 2.5 mg IV and, if required, repeat once after 5 minutes, maximum dose 5 mg
Morphine IM
  • 16–65 years: 5 mg IM and, if required, repeat once after 60 minutes, maximum dose 10 mg
  • 65 years and over: 2.5 mg IM and, if required, repeat once after 60 minutes, maximum dose 5 mg
Methoxyflurane
  • Using a 3 mL self-administered device, instruct the patient to inhale through the mouthpiece and take a couple of gentle breaths to get used to the fruity smell and taste; then take 6–8 deep breaths once only

and/or paracetamol 1000 mg orally once only

and/or ibuprofen 400 mg orally once only

If pain does not improve with medication, escalate as per local CERS protocol.


Nausea and/or vomiting

If nausea and/or vomiting is present, give:

  • metoclopramide 10 mg orally or IV/IM once only (over 20 years only)
  • or ondansetron 4 mg orally or IV/IM. If symptoms persist after 60 minutes, repeat once, maximum dose 8 mg
  • or prochlorperazine 5 mg orally once only or 12.5 mg IV/IM once only

Choice of antiemetic should be determined by cause of symptoms.


Tetanus

If patient has a ‘tetanus-prone’ wound, consider giving a tetanus booster vaccine.

  • Diphtheria and tetanus (ADT booster) vaccine should be given as per the Australian Immunisation Handbook Guide for tetanus prophylaxis in wound management.
  • If ADT booster is not available then diphtheria/tetanus/pertussis (Boostrix) vaccine can be used.
  • If no documented history of a primary vaccination course (3 doses) with a tetanus toxoid-containing vaccine: refer to medical or nurse practitioner or nurse immuniser.
  • If pregnant or breastfeeding: dTpa vaccine (diphtheria-tetanus-acellular pertussis) is recommended. Refer to medical or nurse practitioner or nurse immuniser.

Radiology

Radiology will depend on the working diagnosis. It needs to be requested by a medical or nurse practitioner. If there is concern for urgent radiology, escalate as per local CERS protocol.


Pathology

  • Formal police blood alcohol level, if applicable
  • Preceding event such as syncope and/or special populations such as the elderly or those with multiple comorbidities: FBC, UEC
  • Meets major trauma criteria: FBC, UEC, coags, lipase, group and hold, VBG with lactate
  • Consider alerting blood bank simultaneously
  • Female of childbearing age: urine or serum βHCG

Medications

The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.

Drag the table right to view more columns or turn your phone to landscape

Drug Dose Route Frequency

Compound sodium lactate (Hartmann’s) solution

250 mL

Maximum dose 1000 mL

IV/intraosseous

Bolus

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg

OR

Sodium chloride 0.9%

250 mL

Maximum dose 1000 mL

IV/intraosseous

Bolus

Repeat every 10 minutes (up to 1000 mL) until SBP over 90 mmHg

0.5 mL

IM

Once only

OR

0.5 mL

IM

Where ADT booster not available

Once only

16–65 years
50 microg
Maximum dose 100 microg

65 years and over:
25 microg
Maximum dose 50 microg

IV/intranasal

Pain score 7–10

Repeat once if required after 5 minutes to maximum dose

1 mg

IM

Once only

200 mL

IV infusion over 15 minutes

Once only

Glucose 40% gel
(0.4 g/mL)

15 g

Buccal

Repeat after 15 minutes if required

50 mL

Slow IV injection

Once only

Ibuprofen H, R

400 mg

Oral

Pain score 1–10

Once only

3 mL via self–administered device

Inhalation

Pain score 7–10

Once only

Metoclopramide R

Over 20 years:
10 mg

Oral/IV/IM

Once only

16–65 years
5 mg
Maximum dose 10 mg

65 years and over:
2.5 mg
Maximum dose 5 mg

Pain score 7–10

IV Repeat once if required after 5 minutes
IM Repeat once if required after 60 minutes

Ondansetron

4 mg

Maximum dose 8 mg

Oral/IV/IM

Repeat once if required after 60 minutes

16–65 years:
5 mg
Maximum dose 10 mg

65 years and over:
2.5 mg
Maximum dose 5 mg

Oral

Pain score 4–6

Repeat once if required after 30 minutes to maximum dose

Oxygen

2–15 L/min, device dependent

Inhalation

Continuous

Paracetamol H

1000 mg

Oral

Pain score 1–10

Once only

5 mg

Oral

Once only

OR

12.5 mg

IV/IM

Once only

1 g

IV

Once only

Medications with contraindications or requiring dose adjustment are marked:

  • H for patients with known hepatic impairment
  • R for patients with known renal impairment.

Escalate to medical or nurse practitioner.

References

Hide references

Evidence informed

Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process.

Collaboration

This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol.

Currency Due for review: Jan 2026. Based on a regular review cycle.
Feedback Email ACI-ECIs@health.nsw.gov.au

Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/adult/traumatic-injury

Back to top